Steven McCune
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 2
-
- Advanced Breast Cancer Therapies 5
- Cancer-related cognitive impairment studies 2
- Co-authors
- Tim M. Townes (4 shared papers)Hans‐Georg Kopp (2 shared papers)Niels Reinmuth (2 shared papers)Michael McCleod (2 shared papers)Davey B. Daniel (2 shared papers)Ahad A. Sadiq (2 shared papers)Howard West (2 shared papers)Maen Hussein (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (3 papers)JAMA (1 paper)Clinical Cancer Research (1 paper)Journal of Geriatric Oncology (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Steven McCune
19 papers receiving 1.6k citations
Steven McCune's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 815
- Immunology 240
- Genetics 99
- Cancer Research 112
Countries citing papers authored by Steven McCune
This map shows the geographic impact of Steven McCune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven McCune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven McCune more than expected).
Fields of papers citing papers by Steven McCune
This network shows the impact of papers produced by Steven McCune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven McCune. The network helps show where Steven McCune may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven McCune, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 1137 |
| 2 | 1997 | 218 | |
| 3 | 2004 | 54 | |
| 4 | 2002 | 31 | |
| 5 | 1994 | 29 | |
| 6 | 2021 | 24 | |
| 7 | 2021 | 23 | |
| 8 | 2023 | 17 | |
| 9 | 2021 | 10 | |
| 10 | 2001 | 9 | |
| 11 | 1994 | 9 | |
| 12 | 2019 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2018 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2022 | 1 |
About Steven McCune
Steven McCune is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Genetics, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Advanced Breast Cancer Therapies (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), CRISPR and Genetic Engineering (3 papers), Lung Cancer Research Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Virus-based gene therapy research (2 papers) and Cancer-related cognitive impairment studies (2 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (815 citations), Immunology (240 citations), Genetics (99 citations) and Cancer Research (112 citations). Steven McCune has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Tim M. Townes, Hans‐Georg Kopp, Niels Reinmuth, Michael McCleod, Davey B. Daniel, Ahad A. Sadiq, Howard West, Maen Hussein, Marcin Kowanetz and Wei Lin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, JAMA, Clinical Cancer Research and Journal of Geriatric Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.